Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(17%)
Results Posted
75%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
1
8%
Ph phase_1
1
8%
Ph phase_2
5
42%
Ph not_applicable
4
33%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
5(45.5%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
Recruiting2
unknown2
Not yet recruiting2
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 25 (45.5%)
Phase 31 (9.1%)
N/A4 (36.4%)

Trials by Status

terminated18%
completed433%
enrolling_by_invitation18%
recruiting217%
unknown217%
not_yet_recruiting217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12